By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856


SEARCH JOBS


Industry
Biotechnology






Company News
Omeros (OMER) To Present At The Needham Healthcare Conference 4/3/2017 1:01:49 PM
Omeros (OMER) Reports More Positive Data In OMS721 Phase II Trial In Renal Diseases 3/30/2017 7:02:44 AM
Omeros (OMER) Announces OMS721 Presentation At Annual Meeting Of The European Society For Blood And Marrow Transplantation 3/28/2017 7:42:58 AM
Omeros (OMER) To Present Results From Dose-Ranging Stage Of OMS721 Clinical Trial In Atypical Hemolytic Uremic Syndrome At World Congress Of Nephrology 3/27/2017 7:51:38 AM
Omeros (OMER) Reports Fourth Quarter And Year-End 2016 Financial Results 3/17/2017 6:31:45 AM
Omeros (OMER) To Announce Fourth Quarter And Year-End 2016 Financial Results On March 16, 2017 3/10/2017 6:30:40 AM
Omeros (OMER) To Present At Cowen and Company Annual Health Care Conference 3/2/2017 7:44:52 AM
Omeros (OMER) Reports Additional Positive Results From OMS721 Phase II Trial In Patients With Stem Cell Transplant-Associated Thrombotic Microangiopathy 3/1/2017 7:43:04 AM
Data From Omeros (OMER)’ OMS721 Phase 2 Clinical Trial In Patients With Stem Cell Transplant-Associated TMA To Be Presented At International Transplant Conference 12/7/2016 11:11:02 AM
Omeros (OMER) Extending Compassionate Use For Pediatric Patient No Longer Requiring Dialysis After OMS721 Treatment 12/6/2016 9:18:13 AM
12345678910...
//-->